CRISPR used to treat Duchenne muscular dystrophy in mice
A study has shown that CRISPR can be used as a regenerative technique to treat Duchenne muscular dystrophy, which could be developed as a therapeutic option for humans.
List view / Grid view
A study has shown that CRISPR can be used as a regenerative technique to treat Duchenne muscular dystrophy, which could be developed as a therapeutic option for humans.
Researchers have created a new technology which enabled them to discover more about the causes of Huntington’s disease and which can be used to test drugs.
The memory of mice with Alzheimer's greatly improved after they were injected with two newly discovered short peptides.
A new study has shown a new mechanism of controlling fat production in the body which could lead to new therapies to treat obesity.
A study has shown that a mutated form of the Ebola virus protects macaque models against the disease, demonstrating an opportunity for a drug target.
Chronic inflammatory processes in ageing brains lead to lymphoma cells that have entered the brain tissue being retained.
An experiment with mice has successively blocked the immune system's T cells from killing transplanted cells.
Researchers have discovered a particular protein that is required for enterovirus replication and survival, presenting a therapeutic target.
A study has found a protein which, when depleted, resulted in Alzheimer’s disease symptoms appearing in mouse and brain tissue models.
A team has used a lentiviral capsid-based bionanoparticle system to deliver CRISPR-Cas9 gene editing therapies, reducing undesired effects.
New research findings suggest that gut microbiota may regulate lupus flares in pregnant women, presenting a therapeutic target.
A new drug discovery strategy predicts the clinical actions of new compounds to promote desired clinical responses and avoid side effects.
Scientists have discovered a molecular pathway that contributes to PAH development, which may lead to a new drug target for the disease.
Researchers have discovered that B cells aid T cells in fighting cancer, which could be an area of development for immunotherapies.
A potential treatment for polycystic kidney disease has shown positive results in animal testing.